Dare Bioscience Net Worth
Dare Bioscience Net Worth Breakdown | DARE |
Dare Bioscience Net Worth Analysis
Dare Bioscience's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Dare Bioscience's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Dare Bioscience's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Dare Bioscience's net worth analysis. One common approach is to calculate Dare Bioscience's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Dare Bioscience's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Dare Bioscience's net worth. This approach calculates the present value of Dare Bioscience's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Dare Bioscience's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Dare Bioscience's net worth. This involves comparing Dare Bioscience's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Dare Bioscience's net worth relative to its peers.
To determine if Dare Bioscience is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Dare Bioscience's net worth research are outlined below:
| Dare Bioscience generated a negative expected return over the last 90 days | |
| Dare Bioscience has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 9.78 K. Net Loss for the year was (4.05 M) with loss before overhead, payroll, taxes, and interest of (13.22 M). |
Dare Bioscience uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Dare Bioscience. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Dare Bioscience's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Follow Dare Bioscience's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 21.42 M.Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Dare Bioscience insiders, such as employees or executives, is commonly permitted as long as it does not rely on Dare Bioscience's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Dare Bioscience insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Dare Bioscience time-series forecasting models is one of many Dare Bioscience's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Dare Bioscience's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Dare Bioscience Earnings per Share Projection vs Actual
Dare Bioscience Corporate Management
| David Friend | Chief Officer | Profile | |
| MarDee HaringLayton | Chief Officer | Profile | |
| John Fair | Chief Business Officer | Profile | |
| Lisa WaltersHoffert | Executive Officer | Profile | |
| Mark Walters | Vice Operations | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dare Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Dare Stock refer to our How to Trade Dare Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dare Bioscience. If investors know Dare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dare Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Dare Bioscience is measured differently than its book value, which is the value of Dare that is recorded on the company's balance sheet. Investors also form their own opinion of Dare Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Dare Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dare Bioscience's market value can be influenced by many factors that don't directly affect Dare Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dare Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dare Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dare Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.